Bone Spur Market - Forecast till 2030

Bone Spur Market Size, Trends And Growth Analysis By Type (Knee, Spine, And Others), By Diagnosis (Radiologic Testing, And Others), By Treatment (Medication, Surgery, And Others), By End User- Forecast Till 2030

ID: MRFR/MED/2547-HCR | December 2022 | Region: Global | 82 Pages         

Bone Spur Market Speak to Analyst Request a Free Sample

Bone Spur Market Overview


The Bone Spur Market is projected to reach USD 792.4 Million by 2030 at 7.2% CAGR during the forecast period 2022-2030


Osteophyte or bone spurs are bony projections that grow along the edges of a bone. It can form in any bone but mostly it is found in joints. Bone spurs also occur where tendons, ligaments, and muscles attach to the bone.


Increasing number of cases of bone spur is key driver for the growth of global bone spur market. Advanced diagnosis and treatment options are also driving the growth for the market. Increasing knowledge of this disorder, extended insurance cover, and growing healthcare expenditure are major driving forces of the market.


Study objectives of global bone spur market:



  • To provide detailed analysis of the global market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global market

  • To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by type, diagnosis, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of global bone spur market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global market.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.


 Key players for global bone spur market:                                                    


Some of the key players in this market are: Abbvie, Inc. (US), Eli Lilly and Company (US), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Koninklijke Philips N.V. (Netherlands), Merck & CO., Inc. (US), Pfizer, Inc. (US), Siemens Healthcare GmbH (Germany), and others.


 Segments:                                                                                                                                        


Global bone spur market has been segmented on the basis of type which comprise Knee, Spine, Hip, Shoulder, Fingers, and others. Spine bone spur sub-segmented into posterior osteophytes, anterior osteophytes, and others.


On the basis of diagnosis, the market is segmented into radiologic testing, and others. Radiologic testing is further sub-segmented into X-rays, MRI, ultrasound imaging, myelograms, CT scan.


On the basis of treatments, the market has been segmented into medications, rehabilitation therapy, injections, surgery, and others. Medication includes anti-inflammatory medications, muscle relaxant pain medications, and others. Surgery is sub-segmented into laminotomy, discectomy, foraminotomy, and others. Injections are further sub-segmented into epidural steroid injection, and others.


On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.


Regional analysis of global bone spur market:               


Considering the global scenario of the market, America is holding largest market share. Some major factors are driving the growth in America such as increasing prevalence of osteophytes, large amount of money invested in R&D, and new product development. European market is second largest and countries like Germany and UK are holding the largest market share. Increasing awareness of disorder, increasing healthcare expenditure is major factor for the growth of Asia Pacific bone spur market. While due to lack of knowledge of the disorder and limited access to the healthcare facilities, Middle East & Africa is expected to grow slower than global average growth rate.


The report for Global Bone Spur Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.


Intended Audience



  • Bone spur medicines and devices manufacturers

  • Bone spur medicines, devices, and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 792.4 Million
  CAGR   2022-2030:~7.2%
  Base Year   2021
  Forecast Period   2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Diagnosis, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbvie, Inc. (US), Eli Lilly and Company (US), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Koninklijke Philips N.V. (Netherlands), Merck & CO., Inc. (US), Pfizer, Inc. (US), Siemens Healthcare GmbH (Germany)
  Key Market Opportunities

  • Large amount of money invested in R&D and new product development
  • Increasing awareness of disorder
  • Increasing healthcare expenditure
  •   Key Market Drivers

  • Increasing number of cases of bone spur
  • Advanced diagnosis and treatment


  • Speak to Analyst Ask for Customization